- New options of expensive pneumo-oncological therapy for advanced non-small-cell lung carcinoma (NSCLC) in the first line based on morphological and molecular genetic diagnosis in the Czech Republic2012 | Central Library of Charles University, Faculty of Medicine in Pilsen, First Faculty of Medicine
- The current standard of NSCLC pathological examination in the Czech Republic2022 | Faculty of Medicine in Hradec Králové
- Afatinib as first-line therapy of advanced lung cancer2014 | First Faculty of Medicine
- Immunotherapy in the treatment of lung cancer2017 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma2009 | Central Library of Charles University, First Faculty of Medicine, Second Faculty of Medicine
- Targeted treatment and immunotherapy of advanced non-small cell lung cancer2022 | First Faculty of Medicine
- The present and future of ALK - testing in non-small cell lung carcinoma2017 | Faculty of Medicine in Hradec Králové
- Erlotinib in treatment of NSCLC focusing on patients without EGFR mutation and on combination of erlotinib with bevacizumab2017 | Faculty of Medicine in Pilsen
- Erlotinib in Treatment of NSCLC (Focusing on Patients without EGFR Mutation and on Combination of Erlotinib with Bevacizumab)2017 | Faculty of Medicine in Pilsen
- Perspectives in the treatment of less common mutations in patients with non-small cell lung carcinoma2023 | Publication without faculty affiliation
- Current position of afatinib in the therapy of non-small cell lung carcinoma2017 | Publication without faculty affiliation
- Case studies of patients treated with osimertinib2019 | Second Faculty of Medicine
- Laboratory Parameters Associated with Inflammation Do Not Affect PD-L1 Expression in Non-small Cell Lung Cancer2022 | Central Library of Charles University, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design2021 | First Faculty of Medicine
- Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancer2005 | First Faculty of Medicine, Third Faculty of Medicine
- Differential sensitivity to apoptosome apparatus activation in non-small cell lung carcinoma and the lung2014 | First Faculty of Medicine, Third Faculty of Medicine
- Dual-phase dual-energy CT in patients with lung cancer: assessment of the additional value of iodine quantification in lymph node therapy response2014 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Molecular testing in lung cancer in the era of precision medicine2014 | Faculty of Medicine in Hradec Králové
- Down-regulated expression of apoptosis-associated genes APIP and UACA in non-small cell lung carcinoma2012 | First Faculty of Medicine, Third Faculty of Medicine
- Interplay Between Heme Oxygenase-1 and miR-378 Affects Non-Small Cell Lung Carcinoma Growth, Vascularization, and Metastasis2013 | First Faculty of Medicine
- BOK displays cell death-independent tumor suppressor activity in non-small-cell lung carcinoma2017 | First Faculty of Medicine
- Expression of apoptosome pathway-related transcripts in non-small cell lung cancer2006 | Third Faculty of Medicine
- Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial2003 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine